Photo Courtesy of Google Images
RESTASIS®1 is Now Approved by Health Canada for the Treatment of Dry Eye Disease
November 25, 2010 @ 11:45AM
TORONTO, ON – Allergan is pleased to announce that Health Canada has approved RESTASIS® (cyclosporine) ophthalmic emulsion, 0.05% w/v for the treatment of moderate to moderately severe Dry Eye disease (“Dry Eye”). RESTASIS® is the first prescription eye drop to target the underlying cause of chronic Dry Eye. Read the rest of this entry »
kakonged
